CooperCompanies to Participate in the Jefferies Global Healthcare Conference
CooperCompanies (Nasdaq: COO), a global leader in medical devices, announced its participation in the Jefferies Global Healthcare Conference on June 6, 2024. Brian Andrews, the Executive Vice President, Chief Financial Officer & Treasurer, will represent the company in a session at 1:30 PM ET. The presentation will be accessible via a webcast on the CooperCompanies' investor relations website.
- Participation in a major healthcare conference could increase visibility and investor interest.
- Webcast availability offers easy access for investors and stakeholders to gain insights into the company’s future prospects and strategies.
- No new financial data or business development updates are provided, limiting immediate impact on investor decision-making.
- Webcast reliance could lead to lower engagement if technical issues occur during the live session.
SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a session scheduled at 1:30 PM ET.
The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women’s health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies (“Cooper”) has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
What is the date of CooperCompanies' participation in the Jefferies Global Healthcare Conference?
Who will represent CooperCompanies at the Jefferies Global Healthcare Conference?
Where can investors access the webcast of CooperCompanies' presentation?
What time is CooperCompanies' session at the Jefferies Global Healthcare Conference?
What is the stock symbol for CooperCompanies?
